Contact

Management

 

Executive Committee

Scientific Officers

Dr. Philippe Hantraye – MIRCen /CEA, Scientific Director
Dr. Bernard Zalc – ICM, Deputy Scientific Director

Operational Management

Dr Simone Mergui – CEA, Executive Director
Anne Bellod – ICM, Administration Director and General Secretary
This email address is being protected from spambots. You need JavaScript enabled to view it., business development manager
This email address is being protected from spambots. You need JavaScript enabled to view it., project manager

Representatives of partner organizations

Dr Emmanuel Brouillet – MIRCen / CEA
Dr Brahim Nait Oumesmar – ICM
Pr Philippe Rémy – Groupe Hospitalier Henri Mondor – UPEC
Pr Patrick Aubourg – Neurosciences Bicêtre Paris Sud
Dr Anselme Perrier – BIRD I-Stem
Pr Marie-Anne Colle – BIRD ONIRIS / INRA
Pr Catherine Chiron – Hôpital Necker Enfants Malades – Inserm
Dr Pierre Gressens – Hôpital Robert Debré – Inserm


Scientific coordination of research programs

Cell Therapy : Dr. Anselme Perrier & Pr. Anne-Catherine Bachoud-Levi
Gene therapy : Dr. Marie-Anne Colle & Pr. Patrick Aubourg
In vivo evaluation and therapeutic efficacy : Dr. Emmanuel Brouillet & Pr. Philippe Rémy
Drug Therapy : Dr. Etienne Hirsch & Dr. Bernard Zalc & Dr. Jean-Christophe Corvol

 

Steering Committee

Alix de la Coste - Deputy Director of CEA fundamental research division
Alexis Brice - General director,  IHU-A-ICM
Valérie Thibaudeau - Pôle Infrastructures - Secrétariat Général, Inserm
Olivier Montagne - President, U-PEC
Henri Seegers - President, INRA Angers-Nantes
Florence Favrel-Feuillade -  Director of clinical research and innovation, AP-HP

 

Scientific Advisory Board

Pr. Steve Dunnett, translational Preclinician, Cardiff University (Parkinson's disease, Huntington's Disease, Cell Transplantation)
Anton Ussi -  CFO,EATRIS
Pr. Petra S. Huppi, Clinician, Geneva University Hospitals, Neuro-Development
Pr. Pierre Maquet, Clinician, University of Liege, Functional neuroimaging, Head of Neurology
Pr. Luc Pellerin, Preclinician, University of Lausanne, cerebral metabolism, neuron-astrocyte interplay/interactions
Pr. Olivier Rascol, Clinician, Toulouse University Hospital, Parkinson's disease
Agnès Soubrier, General Director of the LIR (International Research Laboratories), Paris
Frank S Walsh, CEO Ossianix Inc. USA, Neurodegenerative disorders
Pr. Frauke Zipp, Clinician, Director of the Department of Neurology at the University of Mainz, Neuro-immunologist